{"created":"2021-03-01T06:07:52.682752+00:00","id":4092,"links":{},"metadata":{"_buckets":{"deposit":"eeb2050c-9854-4ea3-a27e-8b0be9bd7bf3"},"_deposit":{"id":"4092","owners":[],"pid":{"revision_id":0,"type":"depid","value":"4092"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00004092","sets":["453:454","482:483:484"]},"item_5_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2006-06","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"6","bibliographicPageEnd":"1047","bibliographicPageStart":"1042","bibliographicVolumeNumber":"95","bibliographic_titles":[{"bibliographic_title":"日本内科学会雑誌"},{"bibliographic_title":"日本内科学会雑誌","bibliographic_titleLang":"en"}]}]},"item_5_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"突発性肺胞蛋白症（I-PAP) は，抗GM-CSF自己抗体による自己免疫疾患である．自己抗体が肺胞内のGM-CSF活性をブロックし，最終的に肺胞内のサーファクタントが蓄積する．最近，自己抗体の解析がすすみ，より詳細な機能が明らかになった．治療ではGM－CSF吸入療法の有効性が示された．自己抗体の解析とGM－CSF療法前後の評価は，I-PAPの病態を理解する上できわめて重要である．","subitem_description_type":"Abstract"}]},"item_5_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本内科学会"}]},"item_5_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_5_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00195836","subitem_source_identifier_type":"NCID"}]},"item_5_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00215384","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"渡辺, 雅人"}],"nameIdentifiers":[{"nameIdentifier":"47449","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"中田, 光"}],"nameIdentifiers":[{"nameIdentifier":"47450","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-07-30"}],"displaytype":"detail","filename":"ZI_95(6)_1042-1047.pdf","filesize":[{"value":"1.7 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ZI_95(6)_1042-1047.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/4092/files/ZI_95(6)_1042-1047.pdf"},"version_id":"8445cc18-84cf-44df-b7a4-503f3cbf4979"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"肺胞蛋白症","subitem_subject_scheme":"Other"},{"subitem_subject":"抗GM-CSF自己抗体","subitem_subject_scheme":"Other"},{"subitem_subject":"GM-CSF","subitem_subject_scheme":"Other"},{"subitem_subject":"GM-CSF呼入療法","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"肺胞蛋白症と抗GM-CSF抗体(トピックス　特集　びまん性肺疾患 : 診断と治療の進歩 III.最近の話題）","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"肺胞蛋白症と抗GM-CSF抗体(トピックス　特集　びまん性肺疾患 : 診断と治療の進歩 III.最近の話題）"},{"subitem_title":"肺胞蛋白症と抗GM-CSF抗体(トピックス　特集　びまん性肺疾患 : 診断と治療の進歩 III.最近の話題）","subitem_title_language":"en"}]},"item_type_id":"5","owner":"1","path":["454","484"],"pubdate":{"attribute_name":"公開日","attribute_value":"2012-05-16"},"publish_date":"2012-05-16","publish_status":"0","recid":"4092","relation_version_is_last":true,"title":["肺胞蛋白症と抗GM-CSF抗体(トピックス　特集　びまん性肺疾患 : 診断と治療の進歩 III.最近の話題）"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:37:02.994516+00:00"}